Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M K Brenner

Showing results (81-90 of 226) with videos related to

Pageof 23
Sort By:
International Journal of Cancer|October 23, 2001
Targeting of G(D2)-positive tumor cells by human T lymphocytes engineered to express chimeric T-cell receptor genesC Rossig, C M Bollard, J G Nuchtern, et al.
British Medical Journal (Clinical Research Ed.)|November 3, 1984
Intravenous gammaglobulin treatment in patients with hypogammaglobulinaemiaA So, M K Brenner, I D Hill, et al.
Clinical and Experimental Medicine|December 5, 2002
Cancer vaccines: dream, reality, or nightmare?E Biagi, R F Rousseau, E Yvon, et al.
Clinical and Experimental Immunology|December 1, 1984
Thymoma and hypogammaglobulinaemia with and without T suppressor cellsM K Brenner, J G Reittie, H R Chadda, et al.
Bone Marrow Transplantation|April 3, 2007
Human herpesvirus-6 encephalitis following allogeneic hematopoietic stem cell transplantationT Vu, G Carrum, G Hutton, et al.
Cancer Detection and Prevention|January 1, 1996
Use of gene marking in bone marrow transplantationH E Heslop, C M Rooney, D R Rill, et al.
Blood|May 1, 1988
Analysis of signal transduction in B chronic lymphocytic leukemia cellsH G Drexler, M K Brenner, E Coustan-Smith, et al.
Scandinavian Journal of Haematology|July 1, 1986
Haemolysis after T-cell depleted bone marrow transplantation involving minor AB0 incompatibilityG R Hazlehurst, M K Brenner, J Z Wimperis, et al.
British Journal of Cancer|May 1, 1993
Mechanisms of selective killing of neuroblastoma cells by natural killer cells and lymphokine activated killer cells. Potential for residual disease eradicationN K Foreman, D R Rill, E Coustan-Smith, et al.
Journal of the National Cancer Institute. Monographs|August 26, 1998
Immunotherapy for Epstein-Barr virus-associated cancersC M Rooney, M A Roskrow, C A Smith, et al.
Pageof 23

Showing results (81-90 of 226) with videos related to

Sort By:
Pageof 23
International Journal of Cancer|October 23, 2001
Targeting of G(D2)-positive tumor cells by human T lymphocytes engineered to express chimeric T-cell receptor genesC Rossig, C M Bollard, J G Nuchtern, et al.
British Medical Journal (Clinical Research Ed.)|November 3, 1984
Intravenous gammaglobulin treatment in patients with hypogammaglobulinaemiaA So, M K Brenner, I D Hill, et al.
Clinical and Experimental Medicine|December 5, 2002
Cancer vaccines: dream, reality, or nightmare?E Biagi, R F Rousseau, E Yvon, et al.
Clinical and Experimental Immunology|December 1, 1984
Thymoma and hypogammaglobulinaemia with and without T suppressor cellsM K Brenner, J G Reittie, H R Chadda, et al.
Bone Marrow Transplantation|April 3, 2007
Human herpesvirus-6 encephalitis following allogeneic hematopoietic stem cell transplantationT Vu, G Carrum, G Hutton, et al.
Cancer Detection and Prevention|January 1, 1996
Use of gene marking in bone marrow transplantationH E Heslop, C M Rooney, D R Rill, et al.
Blood|May 1, 1988
Analysis of signal transduction in B chronic lymphocytic leukemia cellsH G Drexler, M K Brenner, E Coustan-Smith, et al.
Scandinavian Journal of Haematology|July 1, 1986
Haemolysis after T-cell depleted bone marrow transplantation involving minor AB0 incompatibilityG R Hazlehurst, M K Brenner, J Z Wimperis, et al.
British Journal of Cancer|May 1, 1993
Mechanisms of selective killing of neuroblastoma cells by natural killer cells and lymphokine activated killer cells. Potential for residual disease eradicationN K Foreman, D R Rill, E Coustan-Smith, et al.
Journal of the National Cancer Institute. Monographs|August 26, 1998
Immunotherapy for Epstein-Barr virus-associated cancersC M Rooney, M A Roskrow, C A Smith, et al.
Pageof 23